Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
04/19/2007 | US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi |
04/19/2007 | US20070088018 Cb1 antagonist compounds |
04/19/2007 | DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases |
04/19/2007 | CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases |
04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |
04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
04/19/2007 | CA2623535A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
04/19/2007 | CA2623500A1 Kinase inhibitors |
04/19/2007 | CA2623202A1 Hydrazide compound and pesticidal use of the same |
04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
04/18/2007 | EP1775295A1 Vanilloid receptor ligands and their use in treatments |
04/18/2007 | EP1775293A1 Antiplatelet agent and process for producing the same |
04/18/2007 | EP1775292A1 Salts of benzimidazole derivative with amines and process for production thereof |
04/18/2007 | EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
04/18/2007 | EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
04/18/2007 | EP1773815A2 Mitotic kinesin inhibitors |
04/18/2007 | EP1773814A2 Substituted oxindol derivatives and medicaments containing the same |
04/18/2007 | EP1773813A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
04/18/2007 | EP1773812A1 3-pyridinylethylcarboxamide derivatives as fungicides |
04/18/2007 | EP1773811A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt |
04/18/2007 | EP1773810A1 New 4-benzylidene-piperidin derivatives |
04/18/2007 | EP1773809A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
04/18/2007 | EP1773808A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
04/18/2007 | EP1773807A2 Kinase inhibitors |
04/18/2007 | EP1773806A1 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi |
04/18/2007 | EP1773805A1 Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
04/18/2007 | EP1773797A2 Aromatic compounds |
04/18/2007 | EP1773788A2 Quinazoline derivatives |
04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
04/18/2007 | EP1773784A2 Anti-inflammatory medicaments |
04/18/2007 | EP1773781A2 Indazoles useful in treating cardiovascular diseases |
04/18/2007 | EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors |
04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
04/18/2007 | EP1773770A1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
04/18/2007 | EP1773763A1 Lysine based compounds |
04/18/2007 | EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
04/18/2007 | EP1773338A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
04/18/2007 | EP1773330A2 Substituted pyrazoles, compositions containing such compounds and methods of use |
04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
04/18/2007 | EP1542989B1 Protein tyrosine kinase inhibitors |
04/18/2007 | EP1514115B1 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/18/2007 | EP1036066B1 Substituted pyrimidine and pyridine herbicides |
04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
04/18/2007 | CN1950365A Indolyl derivatives as liver-X-receptor modulators |
04/18/2007 | CN1950359A Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an IKB kinase inhibitor |
04/18/2007 | CN1950358A Novel gamma secretase inhibitors |
04/18/2007 | CN1950357A Imidazole derivatives used as TAFIA inhibitors |
04/18/2007 | CN1950343A Basic amine compound and use thereof |
04/18/2007 | CN1950340A LXR receptor modulators |
04/18/2007 | CN1950086A Fluorinated 4-azasteroids as androgen receptor modulators |
04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
04/18/2007 | CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
04/18/2007 | CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same |
04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
04/17/2007 | USRE39574 Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
04/17/2007 | US7205417 Spiro compounds |
04/17/2007 | US7205411 for treatment of neuropathic pain |
04/17/2007 | US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting |
04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
04/17/2007 | US7205328 Aids viricide |
04/17/2007 | US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes |
04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |
04/17/2007 | US7205317 Pain management |
04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
04/17/2007 | US7205313 Central nervous system disorders; analgesics; headaches |
04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
04/17/2007 | US7205309 Obesity therapy; administering orlistat |
04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
04/17/2007 | US7205305 Inhibitors of p38 |
04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
04/17/2007 | US7205303 Substituted heterocyclic compounds |
04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
04/17/2007 | US7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
04/17/2007 | US7205299 Indole derivatives having an apoptosis-inducing effect |
04/17/2007 | US7205298 Substituted triazine kinase inhibitors |
04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
04/17/2007 | US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions |
04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |